Trending News

CTA Reporting Restored: FinCEN Extends Filing Deadlines and Signals Revisions to Reporting Requirements After Federal Court Lifts Stay

Corporate Transparency Act Enforceable Again

CTA UPDATE: US District Court Reinstates Reporting Requirement; FinCEN Grants 30-Day Filing Extension

Recent Developments: Nationwide CTA Injunction Lifted, New March 21, 2025, Reporting Deadline Set, and Reporting Rule May Be Modified

The CTA Strikes Back

The Return of the CTA: FinCEN Confirms that Beneficial Ownership Information Reporting Requirements are Back in Effect with a New Deadline of March 21, 2025

US Tariff and Trade Update: Temporary Pause on Canada and Mexico, Tariffs on China, China Retaliation, and What's Next

Tariffs Paused in Mexico and Canada, but not China

Funding Freeze for Health Care Providers – What You Need to Know

FTC Announces Updates to COPPA Rule

William Gaede

Partner

McDermott Will & Emery

Website

Blog

www.mwe.com/insights

Connect

650-815-7435

Professional Biography

William (Bill) Gaede is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Silicon Valley office. Bill co-chairs the Firm’s Life Sciences & Medical Devices group and is a member of the Firm’s Personalized Medicine Team. He also serves as hiring partner for the Silicon Valley office.

More Legal and Business Bylines From William Gaede

Supreme Court to Myriad: Isolated DNA Sequences Are Not Patent-Eligible Subject Matter - (Posted On Saturday, June 15, 2013)
Prometheus Redux: Patentability of Isolated DNA Sequences Are Patentable Subject Matter - (Posted On Wednesday, October 03, 2012)
District Court Power to Enjoin Improper Use Code Is Limited - (Posted On Saturday, September 15, 2012)
Federal Circuit Breathes Life Back Into DNA Patents - (Posted On Friday, August 24, 2012)
Supreme Court: Generic Drug Manufacturers Have Counterclaim Right to Correct Improper Use Codes - (Posted On Monday, June 04, 2012)
Supreme Court Rules in Prometheus: Patent Claims Must Recite “Significantly More” than a Law of Nature - (Posted On Sunday, March 25, 2012)
Can Genes Be Patented? - (Posted On Thursday, September 01, 2011)
Federal Circuit Issues Opinion on Gene Patents in AMP et al v. Myriad Genetics, et al. - (Posted On Tuesday, August 09, 2011)

Current Legal Analysis

President Trump Takes Additional Actions on Reciprocal Tariffs, Shipping, and Digital Services Taxes

by: Nathaniel B. Bolin , David R. Allman

“Claims” Under the FCA, §1983 Claim Denials on Failure-to-Exhaust Grounds, and Limits to FSIA’s Expropriation Exception - SCOTUS Today

by: Stuart M. Gerson

Michigan Overhauls Paid Sick Leave and Minimum Wage Laws

by: Adam S. Forman , Daniel J. Glicker

Federal Court Preliminarily Blocks Key Parts of President Trump’s Orders Restricting DEI at Private Employers

by: T. Scott Kelly , Nonnie L. Shivers

Québec’s Bold Proposal: Empowering Authorities to Safeguard Public Welfare During Work Stoppages

by: Kevin MacNeill , Ryan Martin

Beltway Buzz, February 21, 2025

by: James J. Plunkett

Second Circuit Upholds Reverse Redlining Verdict Against Mortgage Lender

by: A.J. S. Dhaliwal , Mehul N. Madia

Trump Executive Order Requires Independent Agencies to Submit Regulations for Presidential Review

by: A.J. S. Dhaliwal , Mehul N. Madia

Upcoming Events

Feb

25

2025

Navigating Double Patenting in the USPTO Era of Rulemaking

Mar

5

2025

Workplace Wellness: Managing Stress & Anxiety for Peak Performance in Uncertain Times

Feb

25

2025

Trade Secrets and Patents: A Comprehensive Approach to Protecting Intellectual Property

Feb

26

2025

Recharge Your Battery Knowledge: An Overview of U.S. and EU Regulatory Requirements

Print